p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation
Open Access
- 7 September 2018
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 24 (33) , 3709-3723
Abstract
P21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulationKeywords
This publication has 146 references indexed in Scilit:
- Type II p21-activated kinases (PAKs) are regulated by an autoinhibitory pseudosubstrateProceedings of the National Academy of Sciences, 2012
- Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic CancerCancer Cell, 2012
- Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose MetabolismCell, 2012
- PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signalingOncogene, 2011
- RAS oncogenes: weaving a tumorigenic webNature Reviews Cancer, 2011
- Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13Cancer Immunology, Immunotherapy, 2011
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of Medicine, 2011
- Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancerProceedings of the National Academy of Sciences, 2008
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic AnalysesScience, 2008
- Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cellsBritish Journal of Cancer, 2007